Project Details
Description
An Open Label Extension Study to Assess the Long Term Safety and Efficacy of Dupilumab in Patients > 6 months to < 18 years of age with Atopic Dermatitis
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/17 → 11/30/22 |
Funding
- REGENERON PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.